By Gavin Gibbon
Scent Check can detect coronavirus and product results within 30 to 60 seconds
Abu Dhabi-based G42 Healthcare, a subsidiary of Group 42 (G42) has signed an MoU with Israeli company NanoScent to collaborate on a breakthrough solution which can detect Covid-19 in 30 to 60 seconds.
The Scent Check device can pick up coronavirus from a sample of exhaled nasal hair and can be used in large or small-scale settings.
An air sample is seamlessly captured through an ‘Air trap’, a small bag fitted with a straw in which the tested subject needs to blow nasal air. A machine learning based model is then used to analyse, diagnose and label the volatile organic compounds (VOC Signature) and provide the result of the test in 30 to 60 seconds.
Ashish Koshy, CEO of G42 Healthcare, said: "Through this collaboration with NanoScent, we will be adding another powerful solution to our comprehensive diagnostics portfolio, which already includes PCR and LamPORE testing.”
G42 Healthcare, which has been recently leading the operations of the world’s first Phase III clinical trial for the Covid-19 inactivated vaccine and various other population-scale programs, will conduct thousands of tests of the new solution in the coming weeks to ensure its accuracy prior market launch.
#AbuDhabi-based technology company G42 Healthcare and Israeli company NanoScent, which specialises in scent reading technologies, have signed an MoU to collaborate on a breakthrough solution to detect COVID-19 from scent. pic.twitter.com/wTkXVMTKIZ— مكتب أبوظبي الإعلامي (@admediaoffice) August 19, 2020